menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Immunologic Effects on Metabolic Syndrome and MS

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Comments
  • Overview

    In this interview, Lawrence Sherman and Dr. Ralf Gold discusses the study, "Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis," which was led by researchers, Laura Negrotto and Dr. Raul Carrea. They will also discuss the impact of the drugs on clinical biomarkers and MRI, as well as future research on immunologic effects tied to MS.

    This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

Recommended
Details
Comments
  • Overview

    In this interview, Lawrence Sherman and Dr. Ralf Gold discusses the study, "Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis," which was led by researchers, Laura Negrotto and Dr. Raul Carrea. They will also discuss the impact of the drugs on clinical biomarkers and MRI, as well as future research on immunologic effects tied to MS.

    This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

Programs 9/27/21